Table 2 Biomarkers for serious condition by 30-day mortality
Total N = 414 | Serious condition Present n = 63 | Serious condition Not present n = 351 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alive n = 397 | Deceased n = 17 | Alive n = 57 | Deceased n = 6 | Alive n = 340 | Deceased n = 11 | ||||||||||||||
n | Md (IQR) | (%) | n | Md (IQR) | (%) | n | Md (IQR) | (%) | n | Md (IQR) | (%) | n | Md (IQR) | (%) | n | Md (IQR) | (%) | ||
suPAR | ng/ml | 4.8 (3.5–6.6) | 10.7 (5.8–13.3) | 5.4 (4.4–7.4) | 12.5 (5.8–15.2) | 4.7 (3.5–6.6) | 10.3 (4.5–12.7) | ||||||||||||
suPAR | 0–3.9 | 56 | (14.1) | 0 | (0.0) | 1 | (1.8) | 0 | (0) | 55 | (16.2) | 0 | (0.0) | ||||||
4.0–5.9 | 211 | (53.1) | 5 | (29.4) | 33 | (57.9) | 2 | (33.3) | 178 | (52.4) | 3 | (27.3) | |||||||
6.0–8.9 | 80 | (20.2) | 2 | (11.8) | 14 | (24.6) | 0 | (0) | 66 | (19.4) | 2 | (18.2) | |||||||
≥9 | 50 | (12.6) | 10 | (58.8) | 9 | (15.8) | 4 | (66.7) | 41 | (12.1) | 6 | (54.5) | |||||||
Lactate | mmol/l | 1.7 (1.3–2.3) | 1.8 (1.7–3.3) | 1.6 (1.3–2.0) | 1.8 (1.7–2.0) | 1.7 (1.3–2.4) | 2.8 (1.6–4.9) | ||||||||||||
Lactate | ≤2.2 | 288 | (72.5) | 10 | (63.6) | 45 | (78.9) | 5 | (83.3) | 243 | (71.5) | 5 | (45.5) | ||||||
≥2.3 | 109 | (27.5) | 7 | (36.4) | 12 | (21.1) | 1 | (16.7) | 97 | (28.5) | 6 | (54.5) | |||||||